Grants
Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.
FDA ▾
Critical Path Public Private Partnerships
Evaluating Predictive Methods and Product Performance in Healthy Adults for Pediatric Patients, Case Study: Furosemide (U01)
Kidney Health Initiative (R18)
Predictive in vitro Methods for Characterizing Product Performance, Case Study: Furosemide (U01)
The Use of Polyethylene Glycol in the Pediatric Population (R01)
Increasing the Quality and Efficiency of Clinical Trials (R18)
Development of an Integrated Mathematical Model for Comparative Characterization of Complex Molecules (U01)
Development of Process Simulation and Modeling Tools for Integrated Pharmaceutical Manufacturing Processes (U01)
Post-market surveillance evaluation of authorized generic drug products (U01)
Effect of Therapeutic Class on Generic Drug Substitutions (U01)
Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01)
Data Concepts and Terminology Standards for Clinical Research and Drug Development (U24)